Viewing Study NCT01939366


Ignite Creation Date: 2025-12-24 @ 4:15 PM
Ignite Modification Date: 2026-02-25 @ 8:18 PM
Study NCT ID: NCT01939366
Status: COMPLETED
Last Update Posted: 2021-07-15
First Post: 2013-09-06
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Cebranopadol Efficacy and Safety in Diabetic Patients Suffering From Chronic Pain Caused by Damage to the Nerves
Sponsor: Tris Pharma, Inc.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2013-09-27
Start Date Type: ACTUAL
Primary Completion Date: 2015-01
Primary Completion Date Type: ACTUAL
Completion Date: 2015-01-28
Completion Date Type: ACTUAL
First Submit Date: 2013-09-06
First Submit QC Date: None
Study First Post Date: 2013-09-11
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2015-12-22
Results First Submit QC Date: None
Results First Post Date: 2019-12-26
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2021-07-13
Last Update Post Date: 2021-07-15
Last Update Post Date Type: ACTUAL